Accessibility helpSkip to navigationSkip to contentSkip to footer
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign In
  • Home
  • World
    Sections
    • World Home
    • Middle East war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    Most Read
    • China’s central bank plans policy overhaul as pressure mounts on economy
    • Meta global affairs chief Clegg to be replaced by Republican Kaplan
    • Trump uses New Orleans attack to push security and border agenda
    • Stand-off in South Korea as investigators try to arrest impeached president
    • Dollar surges against the euro and sterling
  • US
    Sections
    • US Home
    • US Economy
    • Investing in America
    • US Companies
    • US Politics & Policy
    • US Presidential Election 2024
    Most Read
    • Meta global affairs chief Clegg to be replaced by Republican Kaplan
    • Trump uses New Orleans attack to push security and border agenda
    • Why it’s hard to be a friend of America
    • Trump’s ‘Maganomics’ will hurt growth, economists tell FT polls
    • Things have to get worse to get better
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Musk is standing in the way as Bezos reaches for orbit
    • Meta global affairs chief Clegg to be replaced by Republican Kaplan
    • Hedge funds Citadel and Millennium gain 15% in 2024
    • Tesla’s annual deliveries drop for first time since 2011
    • Shipowners switch to smaller vessels as world trade reroutes from China
  • Tech
    Sections
    • Tech Home
    • Artificial intelligence
    • Semiconductors
    • Cyber Security
    • Social Media
    Most Read
    • Meta global affairs chief Clegg to be replaced by Republican Kaplan
    • Can France become a global AI powerhouse?
    • US investors in China venture funds race to comply with new tech rules
    • AI-generated phishing scams target corporate executives
    • Nvidia invested $1bn in AI deals in 2024
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Crypto
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
    Most Read
    • Dollar surges against the euro and sterling
    • Hedge funds Citadel and Millennium gain 15% in 2024
    • Ex-crypto chief Do Kwon brought to New York to face fraud charges
    • Gold set to rally further this year, say Wall Street banks
    • Crypto industry dreams of a golden era under Trump
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Musk is standing in the way as Bezos reaches for orbit
    • Why it’s hard to be a friend of America
    • Farage and why Badenoch does not have time to ‘watch this space’
    • Things have to get worse to get better
    • One hundred million fans cannot make you famous
  • Lex
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Europe's Start-Up Hubs
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
    Most Read
    • Secrets of an airline points millionaire
    • Can France become a global AI powerhouse?
    • Pensions: the industry where women are in charge
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Social pressure holds back sales of alcohol-free drinks, research finds
    • One hundred million fans cannot make you famous
    • Secrets of an airline points millionaire
    • WNU, the fashionista’s favourite shirtmaker, now makes blazers, too 
    • ‘Do 50 press-ups and a daily meditation’ – the 10 wisdoms of Yohji Yamamoto
  • HTSI
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Lex
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Coronavirus

  • Friday, 29 November, 2024
    Undercover EconomistTim Harford
    Keep vaccines out of politics

    This is a time for treating people as individuals rather than as members of a tribe

  • Saturday, 23 November, 2024
    US politics & policy
    Covid lockdown sceptic is frontrunner to lead Trump health agency

    Jay Bhattacharya at the NIH would be the latest ally of Robert F Kennedy Jr to take a role overseeing US healthcare

    Jay Bhattacharya
  • Friday, 15 November, 2024
    European Union
    EU judges grill von der Leyen’s lawyers over missing text messages

    New York Times has sued European Commission over its refusal to release president’s exchanges with Pfizer chief

    European Commission president Ursula von der Leyen talks with Pfizer chief Albert Bourla during a visit to the company’s factory in Puurs, Belgium, in 2021
  • Monday, 4 November, 2024
    Moral Money
    The corporate researchers hoping to help fend off the next pandemic Premium content

    Abbott Laboratories’ ‘virus hunters’ are tracking disease risks exacerbated by climate change

    Hundreds of the black and white birds caught in action as they take off together towards the camera
  • Wednesday, 9 October, 2024
    Anjana Ahuja
    Marburg outbreak in Rwanda shows some post-pandemic progress

    It is too early to know whether the prompt response to the virus is enough to turn the tide

    Andy Carter illustration of two scientists working on a vaccine as a virus looms large over them
  • Monday, 7 October, 2024
    Europe Express
    EU court to hear case on von der Leyen’s texts with Pfizer next month Premium content

    Also in this newsletter: How greener corporate car fleets could boost competitiveness and the climate goals

    Ursula von der Leyen
  • Tuesday, 1 October, 2024
    UK business
    Most UK businesses given council Covid grants would have survived anyway

    Official report raises questions about cost to taxpayer of pandemic schemes

    A worker wearing a protective face mask serves a drink in a cafe in London in June  2020
  • Monday, 30 September, 2024
    Roche Holding AG
    Roche plans to launch drugs and slash development costs

    Swiss pharma group is a high spender on R&D but has had misses in Alzheimer’s and cancer

    A Roche Research laboratory
  • Monday, 30 September, 2024
    UK economy
    UK economic growth revised lower as households saved more

    Economy expanded 0.5% in second quarter compared with initial estimate of 0.6%

    Shoppers cross Oxford Circus in London, UK
  • Monday, 23 September, 2024
    Pharmaceuticals sector
    GSK’s ex-vaccines chief says its jab for a flu-like virus is too expensive

    Emmanuel Hanon criticises former company’s drug after he raises $100mn for rival product

    Emmanuel Hanon
  • Thursday, 12 September, 2024
    Special ReportFT Health: Communicable Diseases
    Bird flu and mpox show little learnt from Covid about future pandemics

    More aggressive actions and better co-ordinated responses needed to contain viruses, say public health experts

    Several workers dressed in white protective coveralls are attending to rows of chickens inside a poultry farm
  • Thursday, 12 September, 2024
    Thomas Frieden
    We must strengthen public health surveillance to stop disease outbreaks

    Flying blind is dangerous. Technology can build on the basics of local and national data collection

    An individual wearing a white protective lab coat, gloves, and glasses is opening what seems to be a cryogenic tank
  • Thursday, 12 September, 2024
    Special ReportFT Health: Communicable Diseases
    Public health in global south faces vaccine cold storage challenge

    Issue hampers effort to exploit mRNA technology’s promise in tackling deadly viral outbreaks

    A female healthcare worker prepares a vaccine. Behind her in a chair is a woman and her baby
  • Thursday, 12 September, 2024
    Special ReportFT Health: Communicable Diseases
    Inadequate diagnostics increase chances of another pandemic

    Early warning system requires roll out of latest testing techniques, Covid levels of co-operation and greater regulatory harmonisation

    a group of people wearing protective gear working in a large room, likely a testing or medical setup
  • Wednesday, 4 September, 2024
    Disease control and prevention
    EU still not ‘fully prepared’ for next health crisis, warns audit body

    European Court of Auditors says closer co-operation on data and testing would help fix shortcomings exposed by Covid

    A person wearing personal protective equipment tests a newly arrived passenger for Covid at Rome airport in 2020
  • Tuesday, 3 September, 2024
    Europe Express
    What the EU should learn from the woes of its Covid-19 recovery fund Premium content

    Also in this newsletter: Can Brussels block mergers outside of the EU?

    A new giant placard highlighting the European Union’s recovery plan is draped over the facade of the European Commission headquarters
  • Wednesday, 28 August, 2024
    The FT ViewThe editorial board
    The disappointing international response to mpox

    Wealthy world must help Africa prevent a potential regional health catastrophe

    Elisabeth Furaha applies medication on the skin of her child Sagesse Hakizimana who is under treatment for Mpox
  • Tuesday, 27 August, 2024
    Meta Platforms
    Zuckerberg says White House pressured Meta over Covid-19 content

    Chief of Facebook parent says Biden administration was ‘wrong’ and is ready to ‘push back’ in future

    Mark Zuckerberg
  • Friday, 16 August, 2024
    Pharmaceuticals sector
    BioNTech/Pfizer Covid and flu combo vaccine falters in late-stage trial

    Jab makers fall behind Moderna in post-pandemic market with disappointing results

    A close up shot of a Covid vaccine being administered
  • Tuesday, 13 August, 2024
    Antibiotic resistance
    Urban birds may be spreading drug-resistant ‘superbugs’, research shows

    Wild birds are more likely to be carriers of antibiotic-resistant bacteria if they live close to humans, says study

    A duck leads 10 ducklings
  • Tuesday, 13 August, 2024
    This Covid effect won’t last for Asia’s antiviral stocks Premium content

    A surge in infections will boost companies’ shares but this sector’s volatility makes them a poor long-term bet

    Commuters in Tokyo wearing masks
  • Thursday, 8 August, 2024
    Management
    ‘Ill-ish’ and the new rules of working when sick

    A summer Covid outbreak has left staff wondering if they should skip work, come in, or do something in between

    Illustration of a person in their pyjamas and dressing gown being swirled around while they reach for tissues with one hand and a laptop with the other. A hot water bottle, ice pack, notebook, pen, phone, coffee mug and slippers swirl around them
  • Thursday, 18 July, 2024
    UK Covid inquiry
    UK ‘failed’ citizens in planning for wrong pandemic, Covid inquiry says

    Report finds focus on influenza, preparations for no-deal Brexit and ‘groupthink’ strategy hampered response to virus

    Covid Memorial Wall
  • Wednesday, 17 July, 2024
    European Union
    Brussels concealed Covid vaccine contracts details, court finds

    EU court rules that European Commission unlawfully withheld information about procurement

    European Commission president Ursula von der Leyen arrives at the European parliament in Strasbourg on Monday
  • Wednesday, 3 July, 2024
    GSK PLC
    GSK signs €1.4bn mRNA vaccine deal with troubled biotech CureVac

    New agreement hands UK drugmaker control of developing jabs and provides cash injection for German group

    The GSK logo on its headquarters in london
Previous page You are on page 1 Next page

Recommended

Covid-19 vaccines
Covid-19 vaccine tracker: Lowest-income countries lag further behind rest of the world
Coronavirus: free to read
Coronavirus tracker: the latest figures as countries fight the Covid-19 resurgence
Coronavirus tracker
ExplainerCoronavirus economic impact
Pandemic crisis: Global economic impact tracker
News in-depth
Coronavirus economic tracker: latest global fallout

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareersSuppliers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookie PolicyManage CookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

Tools

PortfolioFT AppFT Digital EditionFT EditAlerts HubBusiness School RankingsSubscription ManagerNews feedNewslettersCurrency Converter

Community & Events

FT Live EventsFT ForumsBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2025. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Edition:International
UK
Subscribe for full access

Top sections

  • Home
  • World
    • Middle East war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
  • US
    • US Economy
    • Investing in America
    • US Companies
    • US Politics & Policy
    • US Presidential Election 2024
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
    • Artificial intelligence
    • Semiconductors
    • Cyber Security
    • Social Media
  • Markets
    • Alphaville
    • Markets Data
    • Crypto
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Lex
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Europe's Start-Up Hubs
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports

FT recommends

  • Alphaville
  • FT Edit
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • Visual and data journalism
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Schools
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • FT Digital Edition
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In